Automated Viral Vector Purification via Affinity Chromatography
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for purifying viral vectors are not automated, leading to inefficiencies and potential contamination, which can delay or compromise the effectiveness of cell therapies like CAR T-cell therapy.
Innovation Solution
A method and kit for automated purification of viral vectors using a combination of solution-based cell lysis, column extraction, washing, and elution steps, integrated into a closed, aseptic system with interchangeable chromatography columns and buffers, allowing for the purification of various viral strains in a single process.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Extent of automation
If manual purification methods are used for viral vectors, then flexibility in handling different viral strains is maintained, but automation and productivity are reduced
Solution Approach 1:
The patent employs universal chromatography columns with affinity resin that can bind multiple types of viral vectors (lentivirus, AAV, adenavirus, retrovirus) through common structural components. The automated Xuri Cell Harvester platform provides a multi-functional system that handles diverse viral strains through standardized protocols, eliminating the need for strain-specific manual procedures while maintaining purification effectiveness across different viral types.
2Reliability
If multiple separate steps are used for viral vector purification, then purification quality is maintained, but process time and complexity increase
Solution Approach 1:
The patent combines cell lysis, viral vector binding to affinity resin, washing of contaminants, and elution of purified viral vectors into a single integrated chromatography step. The automated Xuri Cell Harvester performs all these operations sequentially without manual intervention, reducing total process time while maintaining purification quality through optimized buffer compositions and automated timing parameters for each step.
Solution Approach 2:
The automated system maintains continuous operation throughout the purification process, with buffers automatically flowing through the column and viral vectors continuously being bound, washed, and eluted without interruption. This eliminates idle time between manual steps and ensures the purification process proceeds without delays, improving throughput while maintaining reliability through consistent process parameters.
3Reliability
If manual handling is used during purification, then process flexibility is maintained, but contamination risk increases
Solution Approach 1:
The automated Xuri Cell Harvester system performs all purification operations autonomously without requiring manual handling of viral vectors or reagents. The system automatically prepares buffers, loads samples, executes chromatography steps, and collects purified viral vectors, eliminating human contact points that could introduce contamination. The self-service nature of the automation directly improves safety and efficacy by preventing manual contamination while managing system complexity through user-friendly programming.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables efficient, scalable, and safe purification of viral vectors, reducing contamination risks and improving the reliability of downstream processes, particularly for CAR T-cell therapy, by automating the purification of viral vectors in a broadly applicable manner.
Implementation Method 1
flowing said mixture through a chromatography column comprising affinity resin for purification of viral vectors, wherein the viral vectors are adsorbed on said resin in said chromatography column
Implementation Method 2
eluting viral vectors from the resin in the chromatography column into a product container
Data Source
Figure 1
Figure 2~3
Figure 4
AI summary
The present invention relates to a method for purification of viral vectors, more closely it relates to purification of viral vectors from producer cells by using a single automated process. The method comprises the following steps: a) adding producer cells and cell lysis buffer to a processing container; b) mixing said producer cells and cell lysis buffer in said processing container to obtain a mixture; c) flowing said mixture through a chromatography column for purification of viral vectors, wherein the viral vectors are adsorbed on said chromatography column; and d) eluting viral vectors from the chromatography column into a product container.